JIM
BIO icon

Jupiter Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Jupiter Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,727
Closed -$3.24M – 440
2019
Q3 		$3.24M Sell
9,727
-28,741
-75% -$9.38M 0.04% 276
2019
Q2 		$12M Buy
38,468
+13,865
+56% +$4.15M 0.12% 150
2019
Q1 		$7.52M Buy
24,603
+22,703
+1,195% +$6.13M 0.07% 157
2018
Q4 		$441K Buy
+1,900
New +$510K ﹤0.01% 299
2018
Q2 		– Sell
-3,800
Closed -$950K – 377
2018
Q1 		$950K Buy
3,800
+3,600
+1,800% +$917K 0.01% 291
2017
Q4 		$47K Sell
200
-2,333
-92% -$565K ﹤0.01% 341
2017
Q3 		$562K Sell
2,533
-667
-21% -$150K 0.01% 268
2017
Q2 		$724K Buy
3,200
+1,600
+100% +$349K 0.01% 288
2017
Q1 		$318K Buy
+1,600
New +$308K ﹤0.01% 321
2016
Q1 		– Sell
-1,885
Closed -$261K – 469
2015
Q4 		$261K Buy
+1,885
New +$261K 0.01% 212
2014
Q4 		– Sell
-2,684
Closed -$304K – 339
2014
Q3 		$304K Buy
2,684
+1,072
+67% +$127K 0.02% 275
2014
Q2 		$192K Buy
+1,612
New +$197K 0.01% 303

Other funds holding BIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jupiter Investment Management's BIO Position: Q4 2019 in Review

Jupiter Investment Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2019, closing a stake of 9,727 shares — an estimated $3.24M sold.

Jupiter Investment Management first reported a position in BIO in Q2 2014 and held it in 12 quarters. The position peaked at $12M in Q2 2019. 387 funds tracked by Wall St. Rank hold BIO as of Q4 2019.

  • Jupiter Investment Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2019 after selling out during the quarter.
  • Jupiter Investment Management sold 9,727 Bio-Rad Laboratories Class A shares in Q4 2019, an estimated $3.24M.
  • Jupiter Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2014 and held it in 12 quarters.
  • Jupiter Investment Management's Bio-Rad Laboratories Class A position peaked at $12M in Q2 2019.
  • 387 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2019.

Based on Jupiter Investment Management's 13F filing for Q4 2019, filed 3 Feb 2020.